Article Information
History
- April 20, 2020.
Article Versions
- Version 1 (March 30, 2020 - 02:47).
- You are viewing Version 2, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Author Information
- Saranya Thurairatnam1,2,
- Filip Gawecki1,
- Timothy Strangeways1,
- Joseph Perks, BSc5,
- Vatshalan Santhirapala, MB ChB6,
- Jonathan Myers7,
- Hannah C Tighe, BSc8,
- Luke SGE Howard, DPhil FRCP9 and
- Claire L. Shovlin, PhD FRCP*,10
- 1School of Medicine, Imperial College London UK
- 2Hull/York School of Medicine, UK
- 5Respiratory Medicine, Imperial College Healthcare NHS Trust, London UK
- 7Respiratory Medicine, Imperial College Healthcare NHS Trust, London U
- 6Imaging, Imperial College Healthcare NHS Trust, London UK
- 7Division of Cardiology, Veterans Affairs Palo Alto Health Care System (VAPAHCS) and Stanford University, Palo Alto, CA
- 8Respiratory Medicine, Imperial College Healthcare NHS Trust, London UK
- 9National Pulmonary Hypertension Service, Imperial College Healthcare NHS Trust, London UK
- 10NHLI Cardiovascular Sciences Imperial College London, UK; VASCERN HHT European Reference Centre and Respiratory Medicine, Imperial College Healthcare NHS Trust, London UK
- ↵*Corresponding author: Claire L. Shovlin PhD FRCP, Professor of Practice (Clinical and Molecular Medicine), NHLI Cardiovascular Sciences, Imperial Centre for Translational and Experimental Medicine, Imperial College London, Hammersmith Campus, Du Cane Road, London W12 0NN, UK. c.shovlin{at}imperial.ac.uk
Posted April 20, 2020.
Triage assessment of cardiorespiratory risk status based on measurement of the anaerobic threshold, and estimation by activity limitation in patients with pulmonary arteriovenous malformations and hereditary haemorrhagic telangiectasia
